Tasos Konidaris

Insider Reports History

Location
Short Hills, NJ
Signature
/s/ Denis Butkovic, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tasos Konidaris:

Company Role Class Num Shares Value Price $ Report Date Ownership
Amneal Pharmaceuticals, Inc. Executive Vice President & CFO Performance-Based Restricted Stock Units 228,310 $2,018,260 $8.84 03 Mar 2025 Direct
Amneal Pharmaceuticals, Inc. Executive Vice President & CFO Restricted Stock Units 131,945 $1,166,394 $8.84 04 Mar 2025 Direct
Amneal Pharmaceuticals, Inc. Executive Vice President & CFO Class A Common Stock 122,152 $1,151,893 $9.43 15 Aug 2025 Direct
Kadmon Holdings, Inc. Director Stock Option (right to buy) 0 $5.54 09 Nov 2021 Direct

Insider Reports Filed by Tasos Konidaris

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AMRX Amneal Pharmaceuticals, Inc. 13 Aug 2025 3 -$4,663,070 4 Executive Vice President & CFO 15 Aug 2025, 16:30
AMRX Amneal Pharmaceuticals, Inc. 05 Mar 2025 1 -$891,000 4 Executive Vice President & CFO 07 Mar 2025, 16:17
AMRX Amneal Pharmaceuticals, Inc. 03 Mar 2025 14 -$1,367,545 4 Executive Vice President & CFO 05 Mar 2025, 19:53
AMRX Amneal Pharmaceuticals, Inc. 01 Mar 2025 3 -$116,993 4 Executive Vice President & CFO 04 Mar 2025, 18:59
AMRX Amneal Pharmaceuticals, Inc. 12 Mar 2024 3 -$163,495 4 Executive Vice President & CFO 14 Mar 2024, 16:17
AMRX Amneal Pharmaceuticals, Inc. 01 Mar 2024 11 -$269,562 4 Executive Vice President & CFO 05 Mar 2024, 16:56
AMRX Amneal Pharmaceuticals, Inc. 12 Mar 2023 2 $0 4 Executive Vice President & CFO 14 Mar 2023, 16:30
AMRX Amneal Pharmaceuticals, Inc. 03 Mar 2023 4 $0 4 Executive Vice President & CFO 07 Mar 2023, 17:00
AMRX Amneal Pharmaceuticals, Inc. 01 Mar 2023 2 $0 4 Executive Vice President & CFO 03 Mar 2023, 15:30
AMRX Amneal Pharmaceuticals, Inc. 12 Mar 2022 2 $0 4 Executive Vice President & CFO 15 Mar 2022, 17:30
AMRX Amneal Pharmaceuticals, Inc. 01 Mar 2022 4 $0 4 Executive Vice President & CFO 03 Mar 2022, 20:19
/report/000110465921136399-konidaris-tasos-2021-11-09 Kadmon Holdings, Inc. 09 Nov 2021 5 -$2,502,733 4 Director 09 Nov 2021, 16:36
/report/000159396821001309-konidaris-tasos-2021-05-12 Kadmon Holdings, Inc. 12 May 2021 1 $0 4 Director 13 May 2021, 16:04